Long COVID's Respiratory Overlap Explained: Marc A. Sala, MD
By Sabrina McCrear , Marc A. Sala, MD
Marc A. Sala, MD, explains why long COVID overlaps with respiratory disease and how multidisciplinary care improves diagnosis and treatment.
Event Coverage
Explore insights and lessons learned from past Population Health Roundtables. Key takeaways are synthesized and published in AJMC's Population Health, Equity & Outcomes journal.
Bronchiectasis Awareness Gaps Persist: Marc A. Sala, MD
By Sabrina McCrear , Marc A. Sala, MD
Marc A. Sala, MD, discusses bronchiectasis awareness gaps, care strategies, and the importance of cross-specialty communication in patient care.
Closing Gaps in CKM Care Starts With Naming an Owner for Every Patient
Fix cardiorenalmetabolic care gaps: define ownership, task-shift screening, boost uACR testing, and tackle obesity-driven equity barriers.
Escalation of Atopic Dermatitis Care Requires Addressing Barriers
Clinicians at a Chicago Population Health Roundtable say atopic dermatitis biologic therapy is delayed by several key obstacles.
Confronting the "Urgency Gap" Between HFrEF and HFpEF Care
Experts discuss why patients with HFmrEF/HFpEF still receive less urgent, less standardized care than those with reduced ejection fraction.
Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care
At an AJMC roundtable, Atlanta clinicians detailed blood-based biomarker gaps, uncompensated care, and capacity strains slowing Alzheimer diagnosis.
Experts Weigh Vitiligo's Cosmetic Label as Oral Therapies Near
Roundtable reveals vitiligo care gaps: Opzelura leads, insurers still call it cosmetic, and pricey oral JAKs near approval—what’s next?
Panel Confronts Access, Documentation Gaps in Atopic Dermatitis Care
Clinicians spotlight issues that stall pediatric atopic dermatitis escalation and biologic therapy access, despite worsening disease burden.
Gaps Persist in Interstitial Lung Disease Care
Experts at the Washington, DC, Pop Health Roundtable discussed delays in ILD diagnosis, multidisciplinary care, antifibrotic therapy, and insurance barriers.
Emerging Inhaled IPF Therapies Show Promise: Steven D. Nathan, MD
By Sabrina McCrear , Steven D. Nathan, MD
Steven D. Nathan, MD, discusses inhaled treprostinil and why inhaled therapies could mark the next frontier in idiopathic pulmonary fibrosis (IPF) care.
Contributing to National Learning
All roundtable discussions are synthesized into actionable insights and published in AJMC's Population Health, Equity & Outcomes journal. This ensures that regional discussions reach a national audience and contribute to advancing population health practice across the country.
Regional sessions bringing together population health leaders for focused, solutions-driven discussion.
Quick Links
Contact
For inquiries about attending or hosting a roundtable, please submit a participation request.
© 2026 Population Health Roundtables. All rights reserved.